Diseases & Illness |

Diabetes News

New Diabetes Drugs on the Horizon

RSS News Feeds
Disease from Products
Diabetes
Stroke
 All RSS Feeds

At a glance:

A new class of drugs for type II diabetes is under development by Merck and Novartis. 
 
The drugs, known as DPP-4 inhibitors, are meant to stimulate certain hormones that control glucose metabolism. 
 
Both Merck's Januvia and Novartis' Galvus worked well in clinical trials and had fewer side effects than current diabetes medications. 
 
Both drugs are awaiting FDA approval in the US.

Novartis, Merck collaborate on new diabetes drug

Dailyrecord.com - 6/13/2006 2:27 PM

Merck & Co. and Swiss drugmaker Novartis AG are aiming to be first to market with a new class of diabetes drugs designed to use the body's own mechanisms to control blood sugar.
 
The experimental pills, Merck's Januvia and Novartis's Galvus, may offer patients with the most common type of diabetes a new way to keep their disease in check, with fewer side effects than some older medicines, new studies show. The companies are highlighting data on their drugs today at a meeting of the American Diabetes Association in Washington
 
· Read The Full Diabetes Article From Dailyrecord.com -->

· Read All Diabetes News Stories -->

Comments On Diabetes News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: